Icure Pharmaceutical Incorporation (KOSDAQ:175250)

South Korea · Delayed Price · Currency is KRW

1,384.00

-42.00 (-2.95%)

At close: Nov 4, 2026

KOSDAQ:175250 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	51,720	81,092	67,826	78,103	79,498	338,828
Market Cap Growth	-36.22%	19.56%	-13.16%	-1.75%	-76.54%	-27.50%
Enterprise Value	69,957	116,156	86,382	142,444	141,972	399,730
Last Close Price	1384.00	2170.00	1815.00	2090.00	2555.00	13038.48

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	56.63	-	-	-
Forward PE	-	7.87	7.87	7.87	7.87	7.87
PS Ratio	0.45	0.97	1.34	1.38	1.34	5.27
PB Ratio	1.76	2.95	1.10	1.30	0.87	3.43
P/TBV Ratio	1.88	3.13	1.23	1.53	0.95	3.83

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	0.61	1.39	1.70	2.51	2.39	6.22

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.86	1.00	0.66	1.23	0.95	0.75
Net Debt / Equity Ratio	0.58	0.61	0.29	1.09	0.36	0.50
Net Debt / EBITDA Ratio	-3.35	-1.44	-2.51	-3.53	-1.76	-2.23
Net Debt / FCF Ratio	-2.74	-2.13	-0.94	-4.16	-2.15	-1.56
Asset Turnover	1.04	0.74	0.34	0.29	0.27	0.31
Inventory Turnover	7.82	7.24	3.40	4.71	4.72	4.75
Quick Ratio	0.40	0.44	0.53	0.18	0.57	0.66
Current Ratio	0.65	0.62	0.76	0.33	0.73	1.07
Return on Equity (ROE)	-58.78%	-79.17%	5.76%	-42.30%	-44.66%	-35.97%
Return on Assets (ROA)	-5.78%	-10.22%	-6.64%	-8.83%	-7.70%	-9.17%
Return on Invested Capital (ROIC)	-21.46%	-29.60%	-15.56%	-22.02%	-19.80%	-19.54%
Return on Capital Employed (ROCE)	-27.90%	-52.30%	-23.00%	-37.40%	-23.70%	-18.80%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-41.84%	-41.43%	1.77%	-40.04%	-52.54%	-11.26%
FCF Yield	-12.04%	-9.61%	-28.13%	-20.16%	-19.47%	-9.42%
Buyback Yield / Dilution	-0.20%	-	0.32%	-61.23%	-7.58%	-9.71%